A Study Of TAK-981 Given With Monoclonal Antibodies (mAbs) In Adults With Relapsed or Refractory Multiple Myeloma (RRMM)

Clinical trial NCT04776018 · TERMINATED

Trial details

NCT number: NCT04776018
Sponsor: Takeda
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Relapsed and/or Refractory Multiple Myeloma (RRMM)

Start date: 2021-04-20
Primary completion: 2023-08-02
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.